Title : Sitagliptin, An Anti-diabetic Drug, Suppresses Estrogen Deficiency-Induced OsteoporosisIn Vivo and Inhibits RANKL-Induced Osteoclast Formation and Bone Resorption In Vitro.

Pub. Date : 2017

PMID : 28713268






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Further study indicated that sitagliptin inhibited osteoclastogenesis by suppressing AKT and ERK signaling pathways, scavenging ROS activity, and suppressing the Ca2+ oscillation that consequently affects the expression and/or activity of the osteoclast-specific transcription factors, c-Fos and NFATc1. Sitagliptin Phosphate thymoma viral proto-oncogene 1 Mus musculus